Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2005
11/15/2005US6965024 Reactive with ganglioside GD3; cancer treatment
11/15/2005US6965018 Antibodies directed to B7-related polypeptide, BSL-2
11/15/2005US6965017 Melanoma antigens and their use in diagnostic and therapeutic methods
11/15/2005US6964859 Suppressor tRNA system
11/15/2005US6964854 Using monoclonal antibody; hybridomas cell line
11/15/2005US6964770 Recombinant plasmid and a method of controlling the effects of Yersinia pestis
11/15/2005US6964767 Polypeptides; detecting infections using antibodies
11/15/2005US6964199 Methods and compositions for enhanced protein expression and/or growth of cultured cells using co-transcription of a Bcl2 encoding nucleic acid
11/15/2005CA2182315C Expression of heterologous proteins in attenuated bacteria using the htra-promoters
11/12/2005CA2507175A1 Tridimensional simultaneous measurement machine
11/10/2005WO2005106039A1 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer
11/10/2005WO2005106011A2 Process for preparing dipeptidyl iv inhibitors and intermediates therefor
11/10/2005WO2005106010A2 Methods for reducing or eliminating alpha-mannosidase resistant glycans in the production of glycoproteins
11/10/2005WO2005106009A2 Lactoferrin cleavage of neisserial proteins
11/10/2005WO2005105998A1 HUMAN ANTIAMYLOID β PEPTIDE ANTIBODY AND ANTIBODY FRAGMENT THEREOF
11/10/2005WO2005105994A1 Method of disulfide crosslink forming type in vitro protein synthesis
11/10/2005WO2005105846A1 Antibody specifically recognizing resin plasticizer compound
11/10/2005WO2005105156A1 Method for expressing sialylated glycoproteins in mammalian cells and cells thereof
11/10/2005WO2005105144A1 LATENT TGF-β ACTIVATION INHIBITOR
11/10/2005WO2005104763A2 Improved method for identifying peptides in a biological sample
11/10/2005WO2005087810A3 Dimeric fusion proteins and materials and methods for producing them
11/10/2005WO2005073381A3 Method for overproducing a specific recombinant protein with p. cinnabarinus monokaryotic strains
11/10/2005WO2005014779A3 Cyclodextrin affinity purification
11/10/2005WO2004082640A8 Human serum albumin conjugates with therapeutic compounds
11/10/2005WO2004035743A3 Site specific incorporation of keto amino acids into proteins
11/10/2005US20050251885 Method for enhancing yield of recombinant protein production from plants
11/10/2005US20050251871 Novel ubiquitin ligases as therapeutic targets
11/10/2005US20050250936 Modified TGF-beta superfamily proteins
11/10/2005US20050250933 Vaccines
11/10/2005US20050250206 Development of DNA probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes
11/10/2005US20050250186 Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression
11/10/2005US20050250183 In vivo incorporation of unnatural amino acids
11/10/2005US20050250182 Novel genes, compositions, and methods for modulating the unfolded protein response
11/10/2005US20050250180 Secreted protein and polynucleotides encoding them
11/10/2005US20050250177 Preparation, characterization and quantification of active fractions that promote cell growth and recombinant-protein expression
11/10/2005US20050250167 Purified pkb ser 473 kinase and uses thereof
11/10/2005US20050250154 Peptides associated with hepsin protease active site for use in identification of modulators for treatment of cell proliferative disorders
11/10/2005US20050250149 Proteinase inhibitor, precursor thereof and genetic sequences encoding same
11/10/2005US20050250136 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/10/2005US20050250135 Nucleic acid encoding a polypeptide having histidine kinase activity; plasmids and host cells; engineering microorganisms, including Lactobacillus acidophilus, to have an increased ability to tolerate various stress conditions; probiotics
11/10/2005US20050250128 Membranes incorporating recognition moieties
11/10/2005US20050250126 Ztnf13, a tumor necrosis factor
11/10/2005US20050250107 High speed detection, isolation of cells; binding to antibodies; fluorescence classification; purification of antibody from egg yolk
11/10/2005US20050250105 Multiple viral replicon culture systems
11/10/2005US20050250102 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1
11/10/2005US20050249789 Alpha/beta hydrolase-fold enzymes
11/10/2005US20050249753 Hepatitis B virus (HBV); cDNA encoding said variable region; vectors and transformed cells; use to develop monoclonal antibodies for immunotherapy or diagnosis; A transformant E. coli DH5 alpha /YRC-pCRA9Hv (KCTC 1010BP)
11/10/2005US20050249736 Polypeptide compounds for inhibiting angiogenesis and tumor growth
11/10/2005US20050249729 Anti-TRAIL-R antibody
11/10/2005US20050249728 Anti-IGF-I receptor antibody
11/10/2005US20050249726 Useful as therapeutic agent and diagnostic tool for brain tumors which strongly express antigen that is recognized by this antibody
11/10/2005US20050249722 Monoclonal antibodies with enhanced ADCC function
11/10/2005US20050249701 Il-7 Drug substance, composition, preparation and uses
11/10/2005US20050249700 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
11/10/2005CA2565410A1 Method for expressing sialylated glycoproteins in mammalian cells and cells thereof
11/10/2005CA2565125A1 Methods for reducing or eliminating alpha-mannosidase resistant glycans in the production of glycoproteins
11/10/2005CA2564831A1 Method of forming disulfide crosslink in in vitro protein synthesis
11/10/2005CA2564512A1 Artificial immune system: methods for making and use
11/10/2005CA2564432A1 Human anti-amyloid .beta. peptide antibody and fragment of said antibody
11/10/2005CA2564131A1 Novel therapeutic targets in cancer
11/10/2005CA2563903A1 Process for preparing dipeptidyl iv inhibitors and intermediates therefor
11/10/2005CA2563828A1 Improved method for identifying peptides in a biological sample
11/10/2005CA2563064A1 Transgenic animals and uses thereof
11/09/2005EP1593691A1 Method of acquiring human monoclonal antibody inhibiting cancer cell proliferation
11/09/2005EP1593685A1 Peptide antioxidants from soy protein
11/09/2005EP1409531B1 Heterocarpine, a human ghrh-binding protein
11/09/2005EP1355930B1 A method for identification, isolation and production of antigens to a specific pathogen
11/09/2005EP1297172B1 Methods for producing modified glycoproteins
11/09/2005EP1297141B1 A variable region of the monoclonal antibody against the hbv s-surface antigen and a gene encoding the same
11/09/2005EP1287142B1 Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide
11/09/2005EP1285065B1 Long wavelength engineered fluorescent proteins
11/09/2005EP1209230B1 MODIFIED cDNA OF RAT bcl-x GENE AND MODIFIED PROTEIN
11/09/2005EP1165782B1 Improved methods for recombinant peptide production
11/09/2005EP1154692B1 A method of controlling fungal pathogens, and agents useful for same
11/09/2005EP1141245B1 Somatic cells with ablated prp gene and methods of use
11/09/2005EP1111048B1 Neutral amino acid transporter and gene thereof
11/09/2005EP1036179B1 Method for preparing polypeptides with appropriate glycosilation
11/09/2005EP0977874B1 Attenuated salmonella strain used as a vehicle for oral immunization
11/09/2005EP0950068B1 Collagen binding protein compositions and methods of use
11/09/2005EP0939769B1 Vertebrate smoothened proteins
11/09/2005EP0910644B1 Retinoid metabolizing protein
11/09/2005EP0842278B1 Dnase-active protein
11/09/2005EP0833895B1 Immortalized retinal cell lines and their application
11/09/2005EP0792162B1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria
11/09/2005EP0769149B1 Immunoassay for mycophenolic acid
11/09/2005EP0763057B1 Method for proliferating and differentiating b cells, and uses thereof
11/09/2005EP0760857B1 Receptor for oncostatin m
11/09/2005EP0753068B1 Ligands added to adenovirus fiber
11/09/2005EP0751992B1 Vascular endothelial growth factor 2
11/09/2005EP0719330B1 Protocadherin proteins and their uses
11/09/2005CN1695059A Method of diagnosing colon and gastric cancers
11/09/2005CN1694954A Selection and use of lactic acid bacteria for reducing inflammmation caused by helicobacter
11/09/2005CN1694900A EE3-protein family and corresponding DNA sequences
11/09/2005CN1694894A Anti-IL-6 antibodies, compositions, methods and uses
11/09/2005CN1694722A A process for the preparation of a non-toxic anthrax vaccine
11/09/2005CN1694490A Method, equipment and computer program of changed digital color image
11/09/2005CN1226419C Prepn of natural active protein and peptide
11/09/2005CN1226418C Natural active protein and peptide separating and purifying process
11/09/2005CN1226413C Trichina TS88 gene, their protein products and uses
11/09/2005CN1226046C Non-toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor and pharmaceutical compositions containing same
1 ... 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 ... 1125